New research shows a single psilocybin session with therapy can reduce depression in cancer patients for up to two years.

In a phase 2 trial, about half of cancer patients reported sustained reductions in depression and anxiety 2 years after a ...

A single dose of psilocybin provided sustained reductions in depression and anxiety among cancer patients diagnosed with ...

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...

A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...

New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.

In the case of advanced cancer patients, survival varies depending on how they cope with the same stage, according to a study ...

Grail announced that results from the registrational PATHFINDER 2 study of its Galleri multi-cancer early detection test ...

New research shows psilocybin can produce lasting reductions in depression and anxiety in cancer patients with major ...

New results from a clinical trial published by Wiley online in CANCER reveal that a single dose of psilocybin can provide sustained reductions in depression and anxiety in individuals with cancer ...